0001658551-16-000003.txt : 20160822 0001658551-16-000003.hdr.sgml : 20160822 20160822100110 ACCESSION NUMBER: 0001658551-16-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160822 DATE AS OF CHANGE: 20160822 EFFECTIVENESS DATE: 20160822 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Amylyx Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001658551 IRS NUMBER: 464600503 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-269295 FILM NUMBER: 161844386 BUSINESS ADDRESS: STREET 1: 210 BROADWAY STREET 2: #201 CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-571-8872 MAIL ADDRESS: STREET 1: 210 BROADWAY STREET 2: #201 CITY: CAMBRIDGE STATE: MA ZIP: 02139 D 1 primary_doc.xml X0707 D LIVE 0001658551 Amylyx Pharmaceuticals, Inc. 210 BROADWAY #201 CAMBRIDGE MA MASSACHUSETTS 02139 617-571-8872 DELAWARE None None Corporation true 2014 Joshua Cohen 210 Broadway #201 Cambridge MA MASSACHUSETTS 02139 Executive Officer Director Justin Klee 210 Broadway #201 Cambridge MA MASSACHUSETTS 02139 Director Stephen Chubb 210 Broadway #201 Cambridge MA MASSACHUSETTS 02139 Director George Milne 210 Broadway #201 Cambridge MA MASSACHUSETTS 02139 Director Peter Finn c/o Rubin and Rudman LLP 50 Rowes Wharf, 3rd Floor Boston MA MASSACHUSETTS 02110 Executive Officer Pharmaceuticals Decline to Disclose 06b false 2016-08-08 false true false 15000 5000000 4100000 900000 false 19 0 0 620000 false Amylyx Pharmaceuticals, Inc. Peter Finn Peter Finn Secretary 2016-08-22